• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023.

作者信息

Lan Pham Thi, Nguyen Hao Trong, Golparian Daniel, Thuy Van Nguyen Thi, Maatouk Ismael, Unemo Magnus

机构信息

National Hospital of Dermatology and Venereology, Hanoi, Viet Nam.

Ho Chi Minh City Hospital of Dermatology and Venereology, Ho Chi Minh City, Viet Nam.

出版信息

Lancet Reg Health West Pac. 2024 Jun 27;48:101125. doi: 10.1016/j.lanwpc.2024.101125. eCollection 2024 Jul.

DOI:10.1016/j.lanwpc.2024.101125
PMID:39040039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11260586/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faa/11260586/ce733d04c567/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faa/11260586/ce733d04c567/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faa/11260586/ce733d04c567/gr1.jpg

相似文献

1
The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023.世界卫生组织强化淋球菌抗菌药物监测项目（EGASP）发现，2023年越南各地的头孢曲松耐药水平很高。
Lancet Reg Health West Pac. 2024 Jun 27;48:101125. doi: 10.1016/j.lanwpc.2024.101125. eCollection 2024 Jul.
2
High prevalence of ceftriaxone-resistant and XDR in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).2022 - 23年柬埔寨多个城市头孢曲松耐药和广泛耐药的高流行率：世界卫生组织强化淋球菌抗菌药物监测计划（EGASP）
JAC Antimicrob Resist. 2024 Apr 4;6(2):dlae053. doi: 10.1093/jacamr/dlae053. eCollection 2024 Apr.
3
antimicrobial susceptibility trends in Bangkok, Thailand, 2015-21: Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP).2015 - 2021年泰国曼谷的抗菌药物敏感性趋势：强化淋球菌抗菌监测计划（EGASP）
JAC Antimicrob Resist. 2023 Dec 19;5(6):dlad139. doi: 10.1093/jacamr/dlad139. eCollection 2023 Dec.
4
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens.2021 - 2024年，在世界卫生组织（WHO）三个区域的八个WHO加强淋球菌抗菌监测计划国家中，淋病奈瑟菌的四环素耐药水平极高——多西环素暴露后预防措施不太可能影响淋病负担。
J Antimicrob Chemother. 2025 May 2;80(5):1291-1295. doi: 10.1093/jac/dkaf066.
5
Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.增强型淋球菌抗菌药物监测计划（EGASP）数据质量评估，泰国，2015-2021 年。
PLoS One. 2024 Jul 5;19(7):e0305296. doi: 10.1371/journal.pone.0305296. eCollection 2024.
6
The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016.2015-2016 年，泰国曼谷开展全球增强淋球菌抗菌药物监测计划（EGASP）的第一年。
PLoS One. 2018 Nov 9;13(11):e0206419. doi: 10.1371/journal.pone.0206419. eCollection 2018.
7
Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda.根据世卫组织方案在乌干达坎帕拉实施标准化和质量保证的淋球菌抗菌药物监测方案。
Sex Transm Infect. 2021 Jun;97(4):312-316. doi: 10.1136/sextrans-2020-054581. Epub 2020 Oct 20.
8
High susceptibility to the novel antimicrobial zoliflodacin among isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024.2021 - 2024年期间，在世界卫生组织三个区域的八个世界卫生组织加强淋球菌抗菌监测计划国家的分离株中，对新型抗菌药物佐利氟达辛高度敏感。
IJID Reg. 2025 Mar 11;15:100624. doi: 10.1016/j.ijregi.2025.100624. eCollection 2025 Jun.
9
Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.2011 年至 2016 年亚太地区淋病奈瑟菌头孢曲松和阿奇霉素药敏数据的系统评价和调查。
PLoS One. 2019 Apr 3;14(4):e0213312. doi: 10.1371/journal.pone.0213312. eCollection 2019.
10
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.俄罗斯淋球菌抗菌药物敏感性方案（RU-GASP）——2009 年至 2012 年期间淋病奈瑟菌的耐药性和 2011 年和 2012 年的 NG-MAST 基因型。
BMC Infect Dis. 2014 Jun 19;14:342. doi: 10.1186/1471-2334-14-342.

引用本文的文献

1
Antimicrobial resistance in in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study.2023年世界卫生组织强化淋球菌抗菌药物监测计划（EGASP）九个哨点国家的抗菌药物耐药性：一项回顾性观察研究
Lancet Reg Health West Pac. 2025 Aug 21;61:101663. doi: 10.1016/j.lanwpc.2025.101663. eCollection 2025 Aug.
2
Beyond behavioural change: prioritising structural solutions to control bacterial sexually transmitted infections.超越行为改变：优先考虑控制细菌性传播感染的结构性解决方案。
EClinicalMedicine. 2025 Apr 10;83:103198. doi: 10.1016/j.eclinm.2025.103198. eCollection 2025 May.
3

本文引用的文献

1
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.新型 2024 年世卫组织淋病奈瑟菌参考菌株，用于全球实验室调查的质量保证，取代世卫组织淋病奈瑟菌参考菌株 - 表型、遗传和参考基因组特征。
J Antimicrob Chemother. 2024 Aug 1;79(8):1885-1899. doi: 10.1093/jac/dkae176.
2
Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam.越南河内地区淋病奈瑟菌中与penA-60.001等位基因相关的头孢曲松耐药性。
Lancet Infect Dis. 2024 Jun;24(6):e351-e352. doi: 10.1016/S1473-3099(24)00230-5. Epub 2024 May 6.
3
Antimicrobial resistance in and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study.
2022年欧洲淋球菌抗菌监测计划（Euro-GASP）下23个欧洲国家的抗菌药物耐药性及其风险群体：一项回顾性观察研究。
Lancet Reg Health Eur. 2025 May 10;54:101318. doi: 10.1016/j.lanepe.2025.101318. eCollection 2025 Jul.
4
High susceptibility to the novel antimicrobial zoliflodacin among isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024.2021 - 2024年期间，在世界卫生组织三个区域的八个世界卫生组织加强淋球菌抗菌监测计划国家的分离株中，对新型抗菌药物佐利氟达辛高度敏感。
IJID Reg. 2025 Mar 11;15:100624. doi: 10.1016/j.ijregi.2025.100624. eCollection 2025 Jun.
5
High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024.2023 - 2024年越南河内耐头孢曲松淋病奈瑟菌的高流行率
J Infect Dis. 2025 Jul 30;232(1):e73-e77. doi: 10.1093/infdis/jiaf071.
6
Antimicrobial Resistance in Curable Sexually Transmitted Infections.可治愈性传播感染中的抗菌药物耐药性
Curr HIV/AIDS Rep. 2025 Jan 25;22(1):14. doi: 10.1007/s11904-025-00722-7.
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
在淋病中空纤维感染模型中，对头孢曲松单剂量疗法（0.125 - 1克）根除头孢曲松敏感和耐药淋病奈瑟菌菌株进行药效学评估。
J Antimicrob Chemother. 2024 May 2;79(5):1006-1013. doi: 10.1093/jac/dkae063.
4
Ceftriaxone-resistant, multidrug-resistant with a novel mosaic gene, France, June 2022.2022 年 6 月，法国发现一株新型嵌合基因、对头孢曲松耐药、多种药物耐药的淋病奈瑟菌。
Euro Surveill. 2022 Dec;27(50). doi: 10.2807/1560-7917.ES.2022.27.50.2200899.
5
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.世界卫生组织2017 - 18年淋病奈瑟菌全球抗菌药物耐药性监测：一项回顾性观察研究。
Lancet Microbe. 2021 Nov;2(11):e627-e636. doi: 10.1016/S2666-5247(21)00171-3. Epub 2021 Sep 2.
6
A real-time PCR assay for detecting a penA mutation associated with ceftriaxone resistance in Neisseria gonorrhoeae.一种用于检测淋病奈瑟菌中与头孢曲松耐药相关的 penA 突变的实时 PCR 检测方法。
J Glob Antimicrob Resist. 2019 Dec;19:46-49. doi: 10.1016/j.jgar.2019.02.011. Epub 2019 Feb 27.
7
Direct Detection of penA Gene Associated with Ceftriaxone-Resistant Neisseria gonorrhoeae FC428 Strain by Using PCR.应用 PCR 直接检测与头孢曲松耐药淋病奈瑟菌 FC428 株相关的 penA 基因。
Emerg Infect Dis. 2018 Aug;24(8):1573-1575. doi: 10.3201/eid2408.180295.